ArthNow Logo
ArthNow
•3 min read•
✦Reported by Livemint

Rare IPO Bets on End of War and Economic Crisis in Myanmar

Rare IPO Bets on End of War and Economic Crisis in Myanmar
Source: Livemint

Executive Brief • Key Highlights

Fast factual intelligence distilled for busy investors, executives, and answer bots:

  • ✓Concordia Pcl is launching an IPO in Myanmar despite the ongoing civil war and economic crisis.
  • ✓The firm expects to raise $200,000, marking the first main-board listing in over three years.
  • ✓Chairman Than Win said, “We are not listing for short-term sentiment,” as the company prepares for long-term future growth.

Story at a Glance

Category
Indian Markets
Reported By
Livemint
Reading Speed
3 Minute(s)
Market Focus
India Economy

(Bloomberg) -- A Myanmar company is going public in the middle of a civil war and economic downturn, betting on an eventual recovery.

Concordia Pcl expects to raise about $200,000 in an initial public offering that will pave the way for Myanmar’s first main-board stock listing in more than three years. That compares with about $1.2 million raised in the bourse’s first IPO in 2018.

Its chairman, Than Win, said the listing is intended to prepare the family-owned business for longer-term growth rather than fund a major expansion now.

The medical and engineering equipment distributor wants to transform itself into a professionally run company, positioning it to attract foreign investment and expand when Myanmar’s political and economic conditions stabilize.

🔒
Premium Content

Unlock the Full Story with ArthNow Premium

To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.

✓ Full Unabridged Reports✓ Executive Audio Briefs✓ 100% Ad-Free Reading
Verified Publication Source

Livemint

Read the full, original unfiltered story directly on the publisher's portal.

Visit Original Article

This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.